Viewing Study NCT06911606


Ignite Creation Date: 2025-12-26 @ 5:20 PM
Ignite Modification Date: 2025-12-31 @ 11:27 AM
Study NCT ID: NCT06911606
Status: RECRUITING
Last Update Posted: 2025-04-04
First Post: 2025-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)
Sponsor: Guangdong Provincial People's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module